Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma

OBJECTIVE: To evaluate whether the pretreatment Lung Immune Prognostic Index (LIPI) is associated with outcomes in advanced hepatocellular carcinoma (HCC) patients under ICI. METHODS: A two-center retrospective study of patients with HCC treated with immune checkpoint inhibitors (ICIs) between Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tao, Guo, Yusheng, Sun, Bo, Chen, Lei, Ren, Yanqiao, Zhu, Licheng, Zhang, Lijie, Liu, Yiming, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320887/
https://www.ncbi.nlm.nih.gov/pubmed/37408056
http://dx.doi.org/10.1186/s40001-023-01198-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320887/
https://www.ncbi.nlm.nih.gov/pubmed/37408056
http://dx.doi.org/10.1186/s40001-023-01198-0

Ejemplares similares